Skip to content

MiniMed Group MMED Cash & Equivalents

Cash & Equivalents at other companies

MYR Group logo
MYR GroupMYRG
$163.19M+1,398%
Repligen logo
RepligenRGEN
$582.65M-16.4%
NNN REIT logo
NNN REITNNN
$4.57M-10.3%
Piper Sandler logo
Piper SandlerPIPR
$344.43M+173%
Dave, Inc. logo
Dave, Inc.DAVE
$133.33M+184%
Power Integrations logo
Power IntegrationsPOWI
$63.39M+27.8%

Other financials

Income statement

See full
Revenue$790.0M+15.0%
Gross profit$362.0M-8.4%
Operating income-$100.0M-576%
Net income-$119.0M-1,090%
EPS (diluted)-$0.47-1,075%

Balance sheet

See full
Total debt$61.0M
Total equity$3.5B-0.7%
Total assets$4.3B

Cash flow

See full
Operating cash flow-$27.0M-147%
CapEx$167.0M+22.8%
Free cash flow-$194.0M-146%

Valuation

See full
Market cap$4.15B
Enterprise value$4.2B

Returns & leverage

See full
Return on equity-4.3%
Debt / equity
Current ratio1.6×

Where this comes from

Reported directly by MiniMed Group in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: MiniMed Group ’s 10-Q, filed April 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiniMed Group 's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiniMed Group 's cash & equivalents?
MiniMed Group (MMED) reported cash & equivalents of $10M in Q1 2026.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.